Menu
Back to User profile » Dr Kazutaka Shimoda
Papers published by Dr Kazutaka Shimoda:
Survey of Health Literacy Among Japanese Outpatients with Mental Illness
Sato Y, Sugawara N, Kawamata Y, Shimoda K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2023, 19:1369-1378
Published Date: 2 June 2023
Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
Yasui-Furukori N, Kawamata Y, Sasaki T, Yokoyama S, Okayasu H, Shinozaki M, Takeuchi Y, Sato A, Ishikawa T, Komahashi-Sasaki H, Miyazaki K, Fukasawa T, Furukori H, Sugawara N, Shimoda K
Neuropsychiatric Disease and Treatment 2023, 19:921-928
Published Date: 17 April 2023
Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study
Sugawara N, Yasui-Furukori N, Yamada S, Aoki M, Takeuchi Y, Miyazaki K, Shimoda K
Neuropsychiatric Disease and Treatment 2022, 18:891-897
Published Date: 15 April 2022
Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K
Neuropsychiatric Disease and Treatment 2021, 17:1927-1936
Published Date: 15 June 2021
Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
Okayasu H, Shinozaki T, Takano Y, Sugawara N, Fujii K, Yasui-Furukori N, Ozeki Y, Shimoda K
Neuropsychiatric Disease and Treatment 2021, 17:239-249
Published Date: 27 January 2021
The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
Sugawara N, Yasui-Furukori N, Tsuji T, Hayashi S, Ajisawa Y, Ochiai T, Imagawa H, Shimoda K
Neuropsychiatric Disease and Treatment 2020, 16:3063-3070
Published Date: 11 December 2020
Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Neuropsychiatric Disease and Treatment 2020, 16:2229-2236
Published Date: 30 September 2020
Bickerstaff’s Brainstem Encephalitis Suspected as Functional Neurologic Disorders
Okayasu H, Yasui-Furukori N, Kadowaki T, Funakoshi K, Hirata K, Shimoda K
International Medical Case Reports Journal 2020, 13:177-181
Published Date: 18 May 2020
Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Neuropsychiatric Disease and Treatment 2016, 12:427-436
Published Date: 24 February 2016
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K
Neuropsychiatric Disease and Treatment 2014, 10:1793-1798
Published Date: 18 September 2014